Modifiable Risk Factors and Residual Risk Following Coronary Revascularization

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Salim Yusuf, Steven Hawken, Stephanie Ôunpuu et al. · The Lancet · 2004 · 11.8K citations · Full text

Cardiovascular Epidemiology, Cardiovascular Disease, Disease Risk Assessment +13

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

European Heart Journal · 2012 · 8.5K citations · Full text

Vascular Disease, Cardiometabolic Risk, European Guidelines +17

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

Gregory A. Roth, Degu Abate, Kalkidan Hassen Abate et al. · The Lancet · 2018 · 8.5K citations · Full text

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel et al. · New England Journal of Medicine · 2008 · 7.6K citations · Full text

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

Juhani Knuuti, William Wijns, Antti Saraste et al. · European Heart Journal · 2019 · 6.9K citations · Full text